Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies

Journal of General Virology

Volumn 81, Issue 3, 2000, Pages 729-735

  El Kasmi, Karim C ^a,b   Fillon, Sophie ^a   Theisen, Dietmar M ^a,c   Hartter, Heike ^a,b   Brons, Nicolaas H C ^a   Muller, Claude P ^a,b  

^a LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; MATERNAL ANTIBODY; MEASLES VACCINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; SYNTHETIC PEPTIDE; VIRUS HEMAGGLUTININ;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CROSS REACTION; FEMALE; IMMUNIZATION; MALE; MEASLES VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS NEUTRALIZATION;

ANIMALIA; MEASLES VIRUS; RNA VIRUSES;

EID: 0033976278     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-3-729     Document Type: Article

References (28)

1. Albrecht, P., Ennis, F. A., Saltzman, E. J. & Krugman, S. (1977). Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. Journal of Pediatrics 91, 715-718.
2. Alkhatib, G. & Briedis, D. J. (1986). The predicted primary structure of the measles virus hemagglutinin. Virology 150, 479-490.
3. Benjamin, D. C, Berzofsky, J. A., East, I. J., Gurd, F. R., Hannum, C., Leach, S. J., Margoliash, E., Michael, J. G., Miller, A. & Prager, E. M. (1984). The antigenic structure of proteins: a reappraisal. Annual Review of Immunology 2, 67-101.
4. Demotz, S., Lanzavecchia, A., Eisel, U., Niemann, H., Widmann, C. & Corradin, G. (1989). Delineation of several DR-restricted tetanus toxin T cell epitopes. Journal of Immunology 142, 394-402.
5. El Kasmi, K. C., Theisen, D., Brons, N. H. & Muller, C. P. (1998). The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein. Molecular Immunology 35, 905-918.
6. El Kasmi, K. C., Theisen, D., Brons, N. H., Ammerlaan, W., Klingele, M., Truong, A. T. & Muller, C. P. (1999). A hemagglutinin-derived peptidevaccine ignored by virus-neutralising passive antibodies, protects against murine measles encephalitis. Vaccine 17, 2436-2445.
7. Fournier, P., Brons, N. H. C., Berbers, G. A. M., Wiesmüller, K.-H., Fleckenstein, B. T., Schneider, F., Jung, G. & Muller, C. P. (1997). Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis. Journal of General Virology 78, 1295-1302.
8. Giraudon, P. & Wild, T. F. (1985). Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology 144, 46-58.
9. Hu, A. & Norrby, E. (1994). Role of individual cysteine residues in the processing and antigenicity of the measles virus haemagglutinin protein. Journal of General Virology 75, 2173-2181.
10. Huiss, S., Damien, B., Schneider, F. & Muller, C. P. (1997). Characteristics of asymptomatic secondary immune responses to measles virus in late convalescent donors. Clinical Experimental Immunology 109, 416-420.
11. Levely, M. E., Mitchell, M. A. & Nicholas, J. A. (1990). Synthetic immunogens constructed from T-cell and B-cell stimulating peptides (T : B chimeras): preferential stimulation of unique T-and B-cell specificities is influenced by immunogen configuration. Cellular Immunology 125, 65-78.
12. Martineau, P., Leclerc, C. & Hofnung, M. (1996). Modulating the immunological properties of a linear B-cell epitope by insertion into permissive sites of the MalE protein. Molecular Immunology 33, 1345-1358.
13. Muller, C. P., Bunder, R., Mayser, H., Ammon, S., Weinmann, M., Brons, N. H., Schneider, F., Jung, G. & Wiesmuller, K. H. (1995a). Intramolecular immunodominance and intermolecular selection of H2d-restricted peptides define the same immunodominant region of the measles virus fusion protein. Molecular Immunology 32, 37-47.
14. Muller, C. P., Beauverger, P., Schneider, F., Jung, G. & Brons, N. H. C. (1995b). Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus. Journal of General Virology 76, 1371-1380.
15. Niewiesk, S. (1999). Cotton rats (Sigmodon hispidus): an animal model to study the pathogenesis of measles virus infection. Immunology Letters 65, 47-50.
16. Norrby, E. & Hammarskjold, B. (1972). Structural components of measles virus. Microbios 5, 17-29.
17. Obeid, O. E., Partidos, C. D., Howard, C. R. & Steward, M. W. (1995). Protection against morbillivirus-induced encephalitis by immunisation with a rationally designed synthetic peptide vaccine containing B-and T-cell epitopes from the fusion protein of measles virus. Journal of Virology 69, 1420-1428.
18. Partidos, C. D. & Steward, M. W. (1990). Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans. Journal of General Virology 71, 2099-2105.
19. Partidos, C. D. & Steward, M. W. (1992). The effects of a flanking sequence on the immune response to a B and a T cell epitope from the fusion protein of measles virus. Journal of General Virology 73, 1987-1994.
20. Partidos, C. D., Ripley, J., Delmas, A., Obeid, O. E., Denbury, A. & Steward, M. W. (1997). Fine specificity of the antibody response to a synthetic peptide from the fusion protein and protection against measles virus-induced encephalitis in a mouse model. Journal of General Virology 78, 3227-3232.
21. Rehe, G. T., Katona, I. M., Brunswick, M., Wahl, L. M., June, C. H. & Mond, J. J. (1990). Activation of human B lymphocytes by nanogram concentrations of anti-IgM-dextran conjugates. European Journal of Immunology 20, 1837-1842.
22. Sabin, A. B. (1992). My last will and testament on rapid elimination and ultimate global eradication of poliomyelitis and measles. Pediatrics 90, 162-169.
23. Vacchio, M. S., Berzofsky, J. A., Krzych, U., Smith, J. A., Hodes, R. J. & Finnegan, A. (1989). Sequences outside a minimal immunodominant site exert negative effects on recognition by staphylococcal nuclease-specific T cell clones. Journal of Immunology 143, 2814-2819.
24. Varsanyi,T. M., Utter, G. & Norrby, E. (1984). Purification, morphology and antigenic characterization of measles virus envelope components. Journal of General Virology 65, 355-366.
25. Wiesmüller, K.-H., Spahn, G., Handtmann, D., Schneider, F., Jung, G. & Muller, C. P. (1992). Heterogeneity of linear B cell epitopes of the measles virus fusion protein reacting with late convalescent sera. Journal of General Virology 73, 2211-2216.
26. World Health Report (1996). Fighting Disease. Fostering Development. Geneva, Switzerland: WHO.
27. Wortis, H. H., Teutsch, M., Higer, M., Zheng, J. &Parker, D. C. (1995). B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proceedings of the National Academy of Sciences, USA 92, 3348-3352.
28. Ziegler, D., Fournier, P., Berbers, G. A. H., Steuer, H., Wiesmüller, K.-H., Fleckenstein, B., Schneider, F., Jung, G., King, C.-C. & Muller, C. P. (1996). Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies. Journal of General Virology 77, 2479-2489.